CVS Health Corporation $CVS Shares Acquired by Blair William & Co. IL

Blair William & Co. IL lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 0.9% during the second quarter, HoldingsChannel.com reports. The firm owned 62,052 shares of the pharmacy operator’s stock after purchasing an additional 525 shares during the period. Blair William & Co. IL’s holdings in CVS Health were worth $4,280,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. Bell Investment Advisors Inc grew its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC grew its stake in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares during the last quarter. ORG Partners LLC grew its stake in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares during the last quarter. Saudi Central Bank acquired a new stake in CVS Health in the 1st quarter valued at about $34,000. Finally, Livelsberger Financial Advisory acquired a new stake in CVS Health in the 2nd quarter valued at about $35,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.22% of the stock is currently owned by insiders.

CVS Health Trading Up 1.5%

Shares of CVS stock opened at $77.89 on Monday. The firm has a market cap of $98.79 billion, a P/E ratio of 21.76, a PEG ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $79.20. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The firm’s 50-day simple moving average is $72.28 and its 200-day simple moving average is $67.67.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company’s revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio is presently 74.30%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on CVS shares. Cowen reissued a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Cantor Fitzgerald restated an “overweight” rating and issued a $78.00 target price on shares of CVS Health in a report on Tuesday, August 26th. Barclays upped their target price on shares of CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Mizuho upped their target price on shares of CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Sanford C. Bernstein upped their target price on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a report on Friday, September 5th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.80.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.